A spam coalition is warning consumers to be wary of spear-phishing attempts after learning that those who have registered their prescription drug information on certain "product" Web sites may be vulnerable. The Coalition Against Unsolicited Commerce Email (CAUCE) says that Glaxo Smith Klein has notified clients that, as a result of the recent Epsilon data breach, "files containing the e-mail addresses of some of our consumers were accessed by an unauthorized third party" and the "file from which your name and e-mail address were accessed may have identified the product Web site on which you registered." The company is warning clients to "be aware of this situation."
Full Story


If you want to comment on this post, you need to login.